Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic

Clarissa A S Cordova1, Claudriana Locatelli, Evelyn Winter

  • 1aDepartment of Pharmaceutical Sciences bDepartment of Biochemistry cDepartment of Chemistry, Federal University of Santa Catarina dNanovetores Technology S.A., Florianópolis eUniversity of Western Santa Catarina, Videira, SC fFederal University of Tocantins, Araguaína, TO, Brazil.

Anti-Cancer Drugs
|July 27, 2017
PubMed

Insights

Octyl gallate (G8) and its nanoparticle formulation (G8-NVM) effectively inhibited lung metastasis in mice. G8-NVM significantly reduced cancer spread and toxicity compared to free G8, offering a promising anticancer strategy.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Metastasis is a primary cause of cancer mortality, necessitating novel treatments with improved efficacy and reduced toxicity.
  • Gallic acid derivatives, such as octyl gallate (G8), possess demonstrated antitumoral properties.
  • Developing effective anticancer therapies with lower side effects is crucial.

Purpose of the Study:

  • To evaluate the antimetastatic potential of free octyl gallate (G8) and solid lipid nanoparticle-loaded G8 (G8-NVM).
  • To assess the toxicological profile of G8 and G8-NVM in a murine lung metastasis model.

Main Methods:

  • Melanoma cells were inoculated into mice to establish a lung metastasis model.
  • Mice were treated with free G8 or G8-NVM.
  • Metastasis inhibition and toxicological parameters were evaluated.

Main Results:

  • Both G8 and G8-NVM treatments significantly inhibited lung metastasis.
  • G8 treatment led to increased toxicological parameters in mice.
  • G8-NVM treatment largely circumvented the toxic effects observed with free G8.

Conclusions:

  • Octyl gallate exhibits antimetastatic activity, which can be enhanced and made safer through nanotechnology.
  • Solid lipid nanoparticle formulation of G8 (G8-NVM) offers a promising approach to reduce chemotherapy-related toxicity while maintaining anticancer efficacy.
  • Further research into plant-derived compounds and nanotechnology is warranted for improved cancer treatment strategies.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
266
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
268